Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 32,398 | 24,220 | 21,896 | 15,897 | 13,085 |
| Cost of Goods | 21,673 | 15,888 | 10,197 | 7,358 | 6,641 |
| Gross Profit | 10,725 | 8,332 | 11,699 | 8,539 | 6,444 |
| Operating Expenses | 37,464 | 35,656 | 24,529 | 15,190 | 13,527 |
| Operating Income | -26,066 | -26,436 | -12,633 | -6,293 | -6,442 |
| Interest Expense | 549 | 440 | 0 | 433 | 2,144 |
| Other Income | 467 | 196 | -68 | -6,406 | 14 |
| Pre-tax Income | -26,148 | -26,680 | -12,701 | -13,132 | -8,572 |
| Income Tax | 53 | -28 | 18 | -395 | -162 |
| Net Income Continuous | -26,201 | -26,652 | -12,719 | -12,737 | -8,410 |
| Net Income Discontinuous | -250 | -88 | 16 | 521 | 78 |
| Net Income | $-26,451 | $-26,740 | $-12,703 | $-12,216 | $-8,332 |
| EPS Basic Total Ops | -7.32 | -7.25 | -4.52 | -7.70 | -45.90 |
| EPS Basic Continuous Ops | -7.26 | -7.23 | -4.52 | -8.10 | -46.30 |
| EPS Basic Discontinuous Ops | -0.06 | -0.02 | 0.01 | 0.30 | 0.40 |
| EPS Diluted Total Ops | -7.32 | -7.25 | -4.52 | -7.70 | -45.90 |
| EPS Diluted Continuous Ops | -7.26 | -7.23 | -4.52 | -8.10 | -46.30 |
| EPS Diluted Discontinuous Ops | -0.06 | -0.02 | 0.01 | 0.30 | 0.40 |
| EPS Diluted Before Non-Recurring Items | -7.26 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,565 | $-21,912 | $-8,832 | $-2,486 | $-1,959 |